Ahead of BIO-Europe®, Susan Herbert, Executive VP for Global Business Development and Alliance Management at Merck Serono, sat down with our Insight team to discuss the new, evolving landscape that is partnering in the industry.
Shifts include better communication and working with companies that molecules are licensed from and fully taking advantage of the knowledge that company has of the molecule. Merck Serono is also working to be nimble – identifying and moving quickly on deals that are ideal for their portfolio.
How have you seen life science partnering change over the last few years? What’s the main trend you’ve identified?
Merck Serono is just one of 1,841 companies joining us next week in Frankfurt. Are you looking for your next partner? Register to join us November 3-5 at BIO-Europe.